These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 20226733)

  • 1. Effects of melatonin and bright light administration on motor and sensory symptoms of RLS.
    Whittom S; Dumont M; Petit D; Desautels A; Adam B; Lavigne G; Montplaisir J
    Sleep Med; 2010 Apr; 11(4):351-5. PubMed ID: 20226733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circadian rhythm of restless legs syndrome: relationship with biological markers.
    Michaud M; Dumont M; Selmaoui B; Paquet J; Fantini ML; Montplaisir J
    Ann Neurol; 2004 Mar; 55(3):372-80. PubMed ID: 14991815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Test-to-test variability in motor activity during the suggested immobilization test in restless legs patients.
    Haba-Rubio J; Sforza E
    Sleep Med; 2006 Oct; 7(7):561-6. PubMed ID: 16996310
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restless legs syndrome and near-infrared light: An alternative treatment option.
    Mitchell UH; Myrer JW; Johnson AW; Hilton SC
    Physiother Theory Pract; 2011 Jul; 27(5):345-51. PubMed ID: 20977377
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Investigation into the correlation between sensation and leg movement in restless legs syndrome.
    Birinyi PV; Allen RP; Lesage S; Dean T; Earley CJ
    Mov Disord; 2005 Sep; 20(9):1097-103. PubMed ID: 15895424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circadian effects of dopaminergic treatment in restless legs syndrome.
    Garcia-Borreguero D; Serrano C; Larrosa O; Granizo JJ
    Sleep Med; 2004 Jul; 5(4):413-20. PubMed ID: 15223002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between putative indicators of primary restless legs syndrome severity.
    Aksu M; Demirci S; Bara-Jimenez W
    Sleep Med; 2007 Jan; 8(1):84-9. PubMed ID: 16740410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immobilization tests and periodic leg movements in sleep for the diagnosis of restless leg syndrome.
    Montplaisir J; Boucher S; Nicolas A; Lesperance P; Gosselin A; Rompré P; Lavigne G
    Mov Disord; 1998 Mar; 13(2):324-9. PubMed ID: 9539348
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weak relationships between suppression of melatonin and suppression of sleepiness/fatigue in response to light exposure.
    Rüger M; Gordijn MC; Beersma DG; de Vries B; Daan S
    J Sleep Res; 2005 Sep; 14(3):221-7. PubMed ID: 16120096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of rest-duration, time-of-day and their interaction on periodic leg movements while awake in restless legs syndrome.
    Allen RP; Dean T; Earley CJ
    Sleep Med; 2005 Sep; 6(5):429-34. PubMed ID: 16099215
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Diagnosis and symptom rating scale of restless legs syndrome].
    Inoue Y
    Brain Nerve; 2009 May; 61(5):533-8. PubMed ID: 19514513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The acute effect of a low dosage of pramipexole on severe idiopathic restless legs syndrome: an open-label trial.
    Merlino G; Dolso P; Canesin R; Cancelli I; Valente M; Gigli GL
    Neuropsychobiology; 2006; 54(3):195-200. PubMed ID: 17314491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Light visor treatment for jet lag after westward travel across six time zones.
    Boulos Z; Macchi MM; Stürchler MP; Stewart KT; Brainard GC; Suhner A; Wallace G; Steffen R
    Aviat Space Environ Med; 2002 Oct; 73(10):953-63. PubMed ID: 12398256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Night-to-night variability in periodic leg movements in patients with restless legs syndrome.
    Sforza E; Haba-Rubio J
    Sleep Med; 2005 May; 6(3):259-67. PubMed ID: 15854857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-dose hydrocortisone in the evening modulates symptom severity in restless legs syndrome.
    Hornyak M; Rupp A; Riemann D; Feige B; Berger M; Voderholzer U
    Neurology; 2008 Apr; 70(18):1620-2. PubMed ID: 18443313
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blue blocker glasses impede the capacity of bright light to suppress melatonin production.
    Sasseville A; Paquet N; Sévigny J; Hébert M
    J Pineal Res; 2006 Aug; 41(1):73-8. PubMed ID: 16842544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cortical involvement in the sensory and motor symptoms of primary restless legs syndrome.
    Tyvaert L; Houdayer E; Devanne H; Bourriez JL; Derambure P; Monaca C
    Sleep Med; 2009 Dec; 10(10):1090-6. PubMed ID: 19427261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circadian phase delay induced by phototherapeutic devices.
    Paul MA; Miller JC; Gray G; Buick F; Blazeski S; Arendt J
    Aviat Space Environ Med; 2007 Jul; 78(7):645-52. PubMed ID: 17679560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The PAM-RL ambulatory device for detection of periodic leg movements: a validation study.
    Sforza E; Johannes M; Claudio B
    Sleep Med; 2005 Sep; 6(5):407-13. PubMed ID: 16139771
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of two infrared devices in their effectiveness in reducing symptoms associated with RLS.
    Mitchell UH; Johnson AW; Myrer B
    Physiother Theory Pract; 2011 Jul; 27(5):352-9. PubMed ID: 20950168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.